De Novo Truncating Variants in SON Cause Intellectual Disability, Congenital Malformations, and Failure to Thrive.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 27545676.
- Also identified by DOI 10.1016/j.ajhg.2016.06.035 and PMC identifier 5011061.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
SON is a key component of the spliceosomal complex and a critical mediator of constitutive and alternative splicing. Additionally, SON has been shown to influence cell-cycle progression, genomic integrity, and maintenance of pluripotency in stem cell populations. The clear functional relevance of SON in coordinating essential cellular processes and its presence in diverse human tissues suggests that intact SON might be crucial for normal growth and development. However, the phenotypic effects of deleterious germline variants in SON have not been clearly defined. Herein, we describe seven unrelated individuals with de novo variants in SON and propose that deleterious variants in SON are associated with a severe multisystem disorder characterized by developmental delay, persistent feeding difficulties, and congenital malformations, including brain anomalies.
Medical subject headings
- Congenital Abnormalities
- DNA-Binding Proteins
- Developmental Disabilities
- Failure to Thrive
- Intellectual Disability
- Minor Histocompatibility Antigens
- Sequence Deletion